228 related articles for article (PubMed ID: 33573704)
1. Circulating cell-free nucleosomes as biomarker for kidney transplant rejection: a pilot study.
Verhoeven JGHP; Baan CC; Peeters AMA; Clahsen-van Groningen MC; Nieboer D; Herzog M; Eccleston M; Hesselink DA; Boer K
Clin Epigenetics; 2021 Feb; 13(1):32. PubMed ID: 33573704
[TBL] [Abstract][Full Text] [Related]
2. Posttransplant peripheral blood donor-specific interferon-γ enzyme-linked immune spot assay differentiates risk of subclinical rejection and de novo donor-specific alloantibodies in kidney transplant recipients.
Crespo E; Cravedi P; Martorell J; Luque S; Melilli E; Cruzado JM; Jarque M; Meneghini M; Manonelles A; Donadei C; Lloberas N; Gomà M; Grinyó JM; Heeger P; Bestard O
Kidney Int; 2017 Jul; 92(1):201-213. PubMed ID: 28274484
[TBL] [Abstract][Full Text] [Related]
3. B-Cell Activating Factor Predicts Acute Rejection Risk in Kidney Transplant Recipients: A 6-Month Follow-Up Study.
Wang XZ; Wan Z; Xue WJ; Zheng J; Li Y; Ding CG
Front Immunol; 2019; 10():1046. PubMed ID: 31156628
[TBL] [Abstract][Full Text] [Related]
4. Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant.
Friedewald JJ; Kurian SM; Heilman RL; Whisenant TC; Poggio ED; Marsh C; Baliga P; Odim J; Brown MM; Ikle DN; Armstrong BD; Charette JI; Brietigam SS; Sustento-Reodica N; Zhao L; Kandpal M; Salomon DR; Abecassis MM;
Am J Transplant; 2019 Jan; 19(1):98-109. PubMed ID: 29985559
[TBL] [Abstract][Full Text] [Related]
5. Relation between pretransplant serum levels of soluble CD30 and acute rejection during the first 6 months after a kidney transplant.
Shooshtarizadeh T; Mohammadali A; Ossareh S; Ataipour Y
Exp Clin Transplant; 2013 Jun; 11(3):229-33. PubMed ID: 23477385
[TBL] [Abstract][Full Text] [Related]
6. The use of plasma donor-derived, cell-free DNA to monitor acute rejection after kidney transplantation.
Gielis EM; Ledeganck KJ; Dendooven A; Meysman P; Beirnaert C; Laukens K; De Schrijver J; Van Laecke S; Van Biesen W; Emonds MP; De Winter BY; Bosmans JL; Del Favero J; Abramowicz D
Nephrol Dial Transplant; 2020 Apr; 35(4):714-721. PubMed ID: 31106364
[TBL] [Abstract][Full Text] [Related]
7. A Peripheral Blood Gene Expression Signature to Diagnose Subclinical Acute Rejection.
Zhang W; Yi Z; Keung KL; Shang H; Wei C; Cravedi P; Sun Z; Xi C; Woytovich C; Farouk S; Huang W; Banu K; Gallon L; Magee CN; Najafian N; Samaniego M; Djamali A; Alexander SI; Rosales IA; Smith RN; Xiang J; Lerut E; Kuypers D; Naesens M; O'Connell PJ; Colvin R; Menon MC; Murphy B
J Am Soc Nephrol; 2019 Aug; 30(8):1481-1494. PubMed ID: 31278196
[TBL] [Abstract][Full Text] [Related]
8. Graft-derived cell-free DNA, a noninvasive early rejection and graft damage marker in liver transplantation: A prospective, observational, multicenter cohort study.
Schütz E; Fischer A; Beck J; Harden M; Koch M; Wuensch T; Stockmann M; Nashan B; Kollmar O; Matthaei J; Kanzow P; Walson PD; Brockmöller J; Oellerich M
PLoS Med; 2017 Apr; 14(4):e1002286. PubMed ID: 28441386
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Integrated Risk Score Using Omics-Based Biomarkers for the Prediction of Acute Rejection in Kidney Transplantation: A Randomized Prospective Pilot Study.
Lim JH; Chung BH; Lee SH; Lee JS; Kim YH; Han MH; Jung HY; Choi JY; Cho JH; Park SH; Kim YL; Kim CD
Int J Mol Sci; 2024 May; 25(10):. PubMed ID: 38791177
[TBL] [Abstract][Full Text] [Related]
10. Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study.
Van Loon E; Gazut S; Yazdani S; Lerut E; de Loor H; Coemans M; Noël LH; Thorrez L; Van Lommel L; Schuit F; Sprangers B; Kuypers D; Essig M; Gwinner W; Anglicheau D; Marquet P; Naesens M
EBioMedicine; 2019 Aug; 46():463-472. PubMed ID: 31378695
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Performance of Donor-Derived Plasma Cell-Free DNA Fraction for Antibody-Mediated Rejection in Post Renal Transplant Recipients: A Prospective Observational Study.
Zhang H; Zheng C; Li X; Fu Q; Li J; Su Q; Zeng L; Liu Z; Wang J; Huang H; Xu B; Ye M; Liu L; Wang C
Front Immunol; 2020; 11():342. PubMed ID: 32184785
[TBL] [Abstract][Full Text] [Related]
12. Association of soluble human leukocyte antigen-G with acute tubular necrosis in kidney transplant recipients.
Krongvorakul J; Kantachuvesiri S; Ingsathit A; Rattanasiri S; Mongkolsuk T; Kitpoka P; Thammanichanond D
Asian Pac J Allergy Immunol; 2015 Jun; 33(2):117-22. PubMed ID: 26141032
[TBL] [Abstract][Full Text] [Related]
13. HLA-DRB1 mismatch-based identification of donor-derived cell free DNA (dd-cfDNA) as a marker of rejection in heart transplant recipients: A single-institution pilot study.
Sorbini M; Togliatto GM; Simonato E; Boffini M; Cappuccio M; Gambella A; Arruga F; Mora N; Marro M; Caorsi C; Mansouri M; Magistroni P; Delsedime L; Papotti MG; Amoroso A; Rinaldi M; Vaisitti T; Deaglio S
J Heart Lung Transplant; 2021 Aug; 40(8):794-804. PubMed ID: 34134912
[TBL] [Abstract][Full Text] [Related]
14. B-cell activating factor, a predictor of antibody mediated rejection in kidney transplantation recipients.
Pongpirul W; Chancharoenthana W; Pongpirul K; Leelahavanichkul A; Kittikowit W; Jutivorakool K; Nonthasoot B; Avihingsanon Y; Eiam-Ong S; Praditpornsilpa K; Townamchai N
Nephrology (Carlton); 2018 Feb; 23(2):169-174. PubMed ID: 27888573
[TBL] [Abstract][Full Text] [Related]
15. Expression patterns of B cells in acute kidney transplant rejection.
Carpio VN; Noronha Ide L; Martins HL; Jobim LF; Gil BC; Külzer AS; Loreto Mda S; Gonçalves LF; Manfro RC; Veronese FV
Exp Clin Transplant; 2014 Oct; 12(5):405-14. PubMed ID: 25299368
[TBL] [Abstract][Full Text] [Related]
16. Immunosuppression Has Long-Lasting Effects on Circulating Follicular Regulatory T Cells in Kidney Transplant Recipients.
Niu Q; Mendoza Rojas A; Dieterich M; Roelen DL; Clahsen-van Groningen MC; Wang L; van Gelder T; Hesselink DA; van Besouw NM; Baan CC
Front Immunol; 2020; 11():1972. PubMed ID: 32983131
[No Abstract] [Full Text] [Related]
17. Upregulation of microRNA 142-3p in the peripheral blood and urinary cells of kidney transplant recipients with post-transplant graft dysfunction.
Domenico TD; Joelsons G; Montenegro RM; Manfro RC
Braz J Med Biol Res; 2017 Apr; 50(4):e5533. PubMed ID: 28380212
[TBL] [Abstract][Full Text] [Related]
18. Post-transplant donor specific antibody is associated with poor kidney transplant outcomes only when combined with both T-cell-mediated rejection and non-adherence.
Cherukuri A; Mehta R; Sharma A; Sood P; Zeevi A; Tevar AD; Rothstein DM; Hariharan S
Kidney Int; 2019 Jul; 96(1):202-213. PubMed ID: 31029504
[TBL] [Abstract][Full Text] [Related]
19. Subclinical Rejection Phenotypes at 1 Year Post-Transplant and Outcome of Kidney Allografts.
Loupy A; Vernerey D; Tinel C; Aubert O; Duong van Huyen JP; Rabant M; Verine J; Nochy D; Empana JP; Martinez F; Glotz D; Jouven X; Legendre C; Lefaucheur C
J Am Soc Nephrol; 2015 Jul; 26(7):1721-31. PubMed ID: 25556173
[TBL] [Abstract][Full Text] [Related]
20. Urinary Neutrophil Gelatinase-Associated Lipocalin Does Not Distinguish Acute Rejection from Other Causes of Acute Kidney Injury in Pediatric Renal Transplant Recipients.
Seeman T; Vondrak K; Dusek J; Simankova N; Zieg J; Hacek J; Chadimova M; Sopko B; Fortova M
Clin Lab; 2017 Jan; 63(1):111-114. PubMed ID: 28164508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
